Livedo reticularis
Showing 1 - 25 of 58
Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
Recruiting
- Anti Phospholipid Syndrome
-
Beijing, Beijing, China
- +17 more
Dec 3, 2022
APS Secondary to SLE
Recruiting
- Antiphospholipid Syndrome
- Telitacicept
- +5 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 30, 2022
Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi
Completed
- Cutaneous Manifestations
- +7 more
-
Karachi, Sindh, PakistanJinnah Postgraduate Medical Centre
Nov 12, 2021
Liver Cirrhosis Trial in New Delhi (Terlipressin, Standard of Care)
Recruiting
- Liver Cirrhosis
- Terlipressin
- Standard of Care
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Nov 9, 2021
Walking Impairment, Multiple Sclerosis Trial in Canada, United States (ADS-5102, 137 mg, ADS-5102, 274 mg, Placebo)
Completed
- Walking Impairment
- Multiple Sclerosis
- ADS-5102, 137 mg
- +2 more
-
Cullman, Alabama
- +83 more
Dec 19, 2021
Multiple Sclerosis, Walking Impairment Trial in Canada, United States (ADS-5102, 274 mg)
Completed
- Multiple Sclerosis
- Walking Impairment
- ADS-5102, 274 mg
-
Cullman, Alabama
- +91 more
Jan 12, 2022
Parkinson's Disease, Levodopa Induced Dyskinesia (LID) Trial in Worldwide (amantadine HCl ER, Placebo)
Terminated
- Parkinson's Disease
- Levodopa Induced Dyskinesia (LID)
- amantadine HCl ER
- Placebo
-
Tucson, Arizona
- +55 more
Feb 14, 2022
Covid19 Trial in Hvidovre (Amantadine, Lactose monohydrate)
Recruiting
- Covid19
- Amantadine
- Lactose monohydrate
-
Hvidovre, DenmarkCopenhagen University Hospital, Hvidovre
Sep 29, 2021
Aldosterone-producing Adenoma and Unilateral Hyperplasia
Not yet recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- histopathology
-
Chongqing, ChinaThe Third Affiliated Hospital of the Third Military Medical Univ
Jun 28, 2023
Hypertension, Pulmonary Trial in Worldwide (Tadalafil, Placebo, ERA as specific PAH treatment)
Sanfilippo Syndrome Type A (MPS IIIA) Trial in Oakland, Chapel Hill, Ankara (SOBI003)
Completed
- Sanfilippo Syndrome Type A (MPS IIIA)
-
Oakland, California
- +2 more
Feb 2, 2022
NSCLC Trial in Birmingham, Tampa (Carotuximab (TRC105), OPDIVO)
Completed
- Carcinoma, Non-Small-Cell Lung
- Carotuximab (TRC105)
- OPDIVO
-
Birmingham, Alabama
- +1 more
Jun 11, 2020
Emphysema Trial in Worldwide (RePneu Lung Volume Reduction Coil System)
Terminated
- Emphysema
- RePneu Lung Volume Reduction Coil System
-
Birmingham, Alabama
- +28 more
Jul 15, 2021
Amyotrophic Lateral Sclerosis Trial in Lebanon (Albutein 5%, Plasma Exchange)
Completed
- Amyotrophic Lateral Sclerosis
- Albutein 5%
- Plasma Exchange
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Apr 9, 2021
Hemorrhage, Soft Tissue Bleeding Trial in Belgium, Canada, United Kingdom (EVICEL® Fibrin Sealant, SURGICEL® Absorbable
Completed
- Hemorrhage
- Soft Tissue Bleeding
- EVICEL® Fibrin Sealant
- SURGICEL® Absorbable Hemostat
-
Brussels, Belgium
- +12 more
Aug 14, 2020
Cardiac Surgery, Sternal Wound Infection Trial in United States (gentamicin-collagen sponge dipped in saline)
Completed
- Cardiac Surgery
- Sternal Wound Infection
- gentamicin-collagen sponge dipped in saline
-
Birmingham, Alabama
- +42 more
May 4, 2022
Third Degree Burn, Burns, Wound Infection Trial in Phoenix, Madison (StrataGraft Skin Tissue, Cadaver allograft)
Completed
- Third Degree Burn
- +3 more
- StrataGraft Skin Tissue
- Cadaver allograft
-
Phoenix, Arizona
- +1 more
Oct 11, 2019
Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)
Completed
- Small Cell Lung Cancer
- Dinutuximab
- +2 more
-
Anchorage, Alaska
- +225 more
Nov 12, 2020
DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle
Terminated
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- +5 more
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Idiopathic Parkinson's Disease Trial in Worldwide (Istradefylline 40 mg, Istradefylline 20 mg, Placebo)
Completed
- Idiopathic Parkinson's Disease
- Istradefylline 40 mg
- +2 more
-
Phoenix, Arizona
- +88 more
Oct 28, 2020
Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)
Completed
- Breast Cancer
- +4 more
-
New Haven, Connecticut
- +5 more
Jul 13, 2021
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Worldwide (Absorb BVS, XIENCE)
Completed
- Coronary Artery Disease
- +3 more
- Absorb BVS
- XIENCE
-
Birmingham, Alabama
- +119 more
Jul 8, 2022
Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)
Terminated
- Renal Cell Carcinoma
- TRC105 and Axitinib
- Axitinib
-
Birmingham, Alabama
- +38 more
Oct 15, 2020